News &amp; Updates

Neoadjuvant chemotherapy for rectal cancer does not impair postoperative bowel function

Neoadjuvant chemotherapy alone does not seem to trigger low anterior resection syndrome during rectal cancer treatment, a recent study has found.

Neoadjuvant chemotherapy for rectal cancer does not impair postoperative bowel function

$Eribulin mesylate safe, effective in hormone-refractory, triple-negative breast cancers$

Eribulin mesylate safe, effective in hormone-refractory, triple-negative breast cancers

Eribulin mesylate (EM) shows promise as a third-line chemotherapy option for patients with hormone-resistant or triple-negative breast cancer, reports a study.

Eribulin mesylate safe, effective in hormone-refractory, triple-negative breast cancers

Second-line chemo improves survival in advanced biliary tract, gallbladder cancers

Second-line chemotherapy may prolong the life of real-world patients with advanced biliary tract and gallbladder cancers and must therefore be provided to those who are potential candidates for chemotherapy, suggests a study.

Second-line chemo improves survival in advanced biliary tract, gallbladder cancers

Cumulative FIT rounds detect CRC, advanced adenomas better than sigmoidoscopy

Repeated faecal immunochemical testing (FIT) leads to greater detection of colorectal cancer (CRC) and advanced adenomas compared with once-only sigmoidoscopy, as shown in a study.

Cumulative FIT rounds detect CRC, advanced adenomas better than sigmoidoscopy

Bipolar radiofrequency device boasts efficacy in prostate cancer treatment

Focal therapy of significant localized prostate cancer associated with a magnetic resonance imaging (MRI) lesion using bipolar radiofrequency appears effective in ablating cancer, with low rates of genitourinary and rectal side effects, according to a study.

Bipolar radiofrequency device boasts efficacy in prostate cancer treatment

Male sex, impaired fasting glucose predict diabetes incidence during chemo with steroids

As many as 6 percent of cancer patients receiving chemotherapy with dexamethasone develop new-onset diabetes, and this risk is pronounced in men with impaired fasting glucose, according to a study.

Male sex, impaired fasting glucose predict diabetes incidence during chemo with steroids

MRI improves prognostication of prostate cancer metastases, death

An association exists between magnetic resonance imaging (MRI) findings of localized prostate cancer and clinically relevant long-term oncologic outcomes, a study has found.

MRI improves prognostication of prostate cancer metastases, death

Novel endoscopic full-thickness resection device safe, effective for colorectal lesions

A recent study has demonstrated the safety and effectiveness of a full-thickness resection device (FTRD) for endoscopic full-thickness resection (eFTR) of difficult colorectal lesions.

Novel endoscopic full-thickness resection device safe, effective for colorectal lesions